Production (Stage)
Envoy Medical, Inc.
COCH
$1.63
-$0.035-2.10%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -19.52M | -20.80M | -21.07M | -13.64M | -22.94M |
Total Depreciation and Amortization | 200.00K | 173.00K | 173.00K | 153.00K | 140.00K |
Total Amortization of Deferred Charges | 1.29M | 1.32M | 872.00K | 872.00K | 872.00K |
Total Other Non-Cash Items | 728.00K | 2.26M | 1.91M | -5.03M | 5.17M |
Change in Net Operating Assets | 1.47M | -651.00K | -6.33M | -2.90M | -2.91M |
Cash from Operations | -15.83M | -17.69M | -24.45M | -20.54M | -19.67M |
Capital Expenditure | -877.00K | -980.00K | -1.54M | -440.00K | -203.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 0.00 | 0.00 | 0.00 | -542.00K | -- |
Cash from Investing | -877.00K | -980.00K | -1.54M | -982.00K | -203.00K |
Total Debt Issued | 20.00M | 20.00M | 15.00M | 10.50M | 11.00M |
Total Debt Repaid | -1.15M | -1.17M | -820.00K | -820.00K | -820.00K |
Issuance of Common Stock | 434.00K | 2.12M | 2.23M | 1.79M | 1.79M |
Repurchase of Common Stock | -371.00K | -371.00K | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | 1.00M | 1.00M |
Repurchase of Preferred Stock | -- | -- | -1.00M | -1.00M | -1.00M |
Total Dividends Paid | -3.66M | -2.45M | -1.83M | -- | -- |
Other Financing Activities | 1.82M | 1.82M | 0.00 | 11.74M | 11.74M |
Cash from Financing | 17.07M | 19.94M | 13.57M | 23.21M | 23.71M |
Foreign Exchange rate Adjustments | 2.00K | -5.00K | -5.00K | -5.00K | -5.00K |
Miscellaneous Cash Flow Adjustments | 1.00K | 1.00K | -- | -- | -- |
Net Change in Cash | 367.00K | 1.27M | -12.42M | 1.68M | 3.83M |